Masakazu Hayashida

Dr. Masakazu Hayashida

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SYSho Yamazaki
Sho Yamazaki
KYKeisuke Yamaguchi
Keisuke Yamaguchi
ASAkimasa Someya
Akimasa Someya
INIsao Nagaoka
Isao Nagaoka
MHMasakazu Hayashida
Masakazu Hayashida
Neuroinflammation, where inflammatory cytokines are produced in excess, contributes to the pathogenesis of delirium. Microglial cells play a central role in neuroinflammation by producing and releasing inflammatory cytokines in response to infection, tissue damage and neurodegeneration. Dexmedetomidine (DEX) is a sedative, which reduces the incidence of delirium. Thus, we hypothesized that DEX may alleviate delirium by exhibiting anti-inflammatory action on microglia. In the present study, we investigated the anti-inflammatory action of DEX on human microglial HMC3 cells. The results indicated that DEX partially suppressed the IL-6 and IL-8 production by lipopolysaccharide (LPS)-stimulated HMC3 cells as well as the phosphorylation of p38 MAPK and IκB and the translocation of NF-κB. Furthermore, DEX substantially suppressed IL-6 and IL-8 production by unstimulated HMC3 cells as wells as the phosphorylation of p38 MAPK and IκB and the translocation of NF-κB. These observations suggest that DEX exhibits anti-inflammatory action on not only LPS-stimulated but also unstimulated microglial cells via the suppression of inflammatory signaling and cytokine production.

1 February 2017 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Open access
PDF file
IKIzumi Kawagoe
Izumi Kawagoe
MHMasakazu Hayashida
Masakazu Hayashida
YNYusaku Nozumi
Yusaku Nozumi
TBTakamitsu Banno
Takamitsu Banno
SHShunki Hirayama
Shunki Hirayama
EIEiichi Inada
Eiichi Inada
PARTIAL ANOMALOUS PULMONARY venous connection (PAPVC) is a relatively uncommon congenital anomaly, with a reported incidence of 0.4% to 0.7% in the general population.1 x 1 Hughes, C.W. and Rumore, P.C. Anomalous pulmonary veins. Arch Pathol. 1944; 37: 364–366 Google Scholar See all References , 2 x 2 Healey, J.E. Jr. An anatomic survey of anomalous pulmonary veins: Their clinical significance. J Thorac Surg. 1952; 23: 433–444 PubMed | Google Scholar See all References In children, PAPVCs commonly are associated with atrial septal defects (ASDs) and are located primarily on the right side.3 x 3 AboulHosn, J.A., Criley, J.M., and Stringer, W.W. Partial anomalous pulmonary venous return: Case report and review of the literature. Catheter Cardiovasc Interv. 2003; 58: 548–552 Crossref | PubMed | Scopus (23) | Google Scholar See all References , 4 x 4 van de Woestijne, P.C., Verberkmoes, N., and Bogers, A.J. Partial anomalous pulmonary venous connection (including scimitar syndrome). Multimed Man Cardiothorac Surg. 2013; mmt001 Google Scholar See all References In contrast, PAPVCs in adults are found most commonly in the left upper lobe and are very rarely complicated with ASDs.5 x 5 Haramati, L.B., Moche, I.E., and Rivera, V.T. Computed tomography of partial anomalous pulmonary venous connection in adults. J Comput Assist Tomogr. 2003; 7: 743–749 Crossref | Scopus (75) | Google Scholar See all References Surgical correction of a PAPVC is recommended for patients with a pulmonary-to-systemic blood flow ratio (Qp/Qs) of greater than 1.5.3 x 3 AboulHosn, J.A., Criley, J.M., and Stringer, W.W. Partial anomalous pulmonary venous return: Case report and review of the literature. Catheter Cardiovasc Interv. 2003; 58: 548–552 Crossref | PubMed | Scopus (23) | Google Scholar See all References , 6 x 6 El Bardissi, A.W., Dearani, J.A., and Suri, R.M. Left-sided partial anomalous pulmonary venous connections. Ann Thorac Surg. 2008; 85: 1007–1014 Abstract | Full Text | Full Text PDF | PubMed | Scopus (34) | Google Scholar See all References Generally, an isolated PAPVC on the left side can be corrected by a simple procedure without cardiopulmonary bypass (CPB), such as anastomosis of the anomalous vein to the left atrial appendage,6 x 6 El Bardissi, A.W., Dearani, J.A., and Suri, R.M. Left-sided partial anomalous pulmonary venous connections. Ann Thorac Surg. 2008; 85: 1007–1014 Abstract | Full Text | Full Text PDF | PubMed | Scopus (34) | Google Scholar See all References whereas correction of PAPVCs on the right side needs more complicated intracardiac procedures on CPB for rerouting to the left atrium.4 x 4 van de Woestijne, P.C., Verberkmoes, N., and Bogers, A.J. Partial anomalous pulmonary venous connection (including scimitar syndrome). Multimed Man Cardiothorac Surg. 2013; mmt001 Google Scholar See all References

Verified
Journal Article
Open access
PDF file
MSMoe Soeda
Moe Soeda
SOSeii Ohka
Seii Ohka
DNDaisuke Nishizawa
Daisuke Nishizawa
MIMasako Iseki
Masako Iseki
KYKeisuke Yamaguchi
Keisuke Yamaguchi
KIKazutaka Ikeda
Kazutaka Ikeda
Patients with chronic pain are affected psychologically and socially. There are also individual differences in treatment efficacy. Insufficient research has been conducted on genetic polymorphisms that are related to individual differences in the susceptibility to chronic pain. Autoimmune disorders can lead to inflammation and chronic pain; therefore, we focused on the autoimmune-related protease-activated receptor 2 (PAR2/F2RL1) and interleukin 17A (IL-17A/IL17A) genes. PAR2 and IL-17A are associated with autoimmune diseases that lead to chronic pain, and PAR2 regulates T-helper (Th) cell activation and differentiation. We hypothesized that the PAR2 and IL-17A genes are associated with chronic pain. The present study used a case–control design to statistically examine associations between genetic polymorphisms and the vulnerability to chronic pain. The rs2243057 polymorphism of the PAR2 gene and rs3819025 polymorphism of the IL-17A gene were previously reported to be associated with pain- or autoimmune-related phenotypes. Thus, these polymorphisms were investigated in the present study. We found that both rs2243057 and rs3819025 were significantly associated with a susceptibility to chronic pain. The present findings revealed autoimmune-related genetic factors that are involved in individual differences in chronic pain, further aiding understanding of the pathomechanism that underlies chronic pain and possibly contributing to future personalized medicine.

1 February 2018 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
MYMakiko Yamamoto
Makiko Yamamoto
MHMasakazu Hayashida
Masakazu Hayashida
MKMaho Kakemizu-Watanabe
Maho Kakemizu-Watanabe
NANozomi Ando
Nozomi Ando
HMHiroshi Mukaida
Hiroshi Mukaida
EIEiichi Inada
Eiichi Inada

26 September 2023 in Cancers
Verified
Journal Article
Open access
PDF file
DNDaisuke Nishizawa
Daisuke Nishizawa
RMRyozo Morino
Ryozo Morino
RIRie Inoue
Rie Inoue
SOSeii Ohka
Seii Ohka
SKShinya Kasai
Shinya Kasai
KIKazutaka Ikeda
Kazutaka Ikeda
Considerable individual differences are widely observed in the incidence of postoperative nausea and vomiting (PONV). We conducted a genome-wide association study (GWAS) to identify potential candidate single-nucleotide polymorphisms (SNPs) that contribute to PONV by utilizing whole-genome genotyping arrays with more than 950,000 markers. The subjects were 806 patients who provided written informed consent and underwent elective surgery under general anesthesia with propofol or desflurane. The GWAS showed that two SNPs, rs2776262 and rs140703637, in the LOC100506403 and CNTN5 gene regions, respectively, were significantly associated with the frequency of nausea. In another GWAS conducted only on patients who received propofol, rs7212072 and rs12444143 SNPs in the SHISA6 and RBFOX1 gene regions, respectively, were significantly associated with the frequency of nausea as well as the rs2776262 SNP, and the rs45574836 and rs1752136 SNPs in the ATP8B3 and LOC105370198 gene regions, respectively, were significantly associated with vomiting. Among these SNPs, clinical and SNP data were available for the rs45574836 SNP in independent subjects who underwent laparoscopic gynecological surgery, and the association was replicated in these subjects. These results indicate that these SNPs could serve as markers that predict the vulnerability to PONV. Our findings may provide valuable information for achieving satisfactory prophylactic treatment for PONV.

5 March 2022 in Journal of Anesthesia
Verified
Journal Article
Open access
PDF file
KTKazuyo Takeuchi
Kazuyo Takeuchi
MHMasakazu Hayashida
Masakazu Hayashida
OKOsamu Kudoh
Osamu Kudoh
NNNaoko Niimi
Naoko Niimi
KKKumi Kataoka
Kumi Kataoka
KYKeisuke Yamaguchi
Keisuke Yamaguchi
Purpose: This trial was conducted to compare effects of continuing versus withholding single-pill combination tablets consisting of angiotensin receptor blockers (ARBs) and calcium channel blockers (CCBs) on perioperative hemodynamics and clinical outcomes. Methods: Patients undergoing minor abdominal or urological surgery (n = 106) were randomly assigned to Group C, in which ARB/CCB combination tablets were continued until surgery, or Group W, in which they were withheld within 24 h of surgery. Perioperative hemodynamics and clinical outcomes were compared between the Groups. Results: The incidence of hypotension during anesthesia requiring repeated treatment with vasoconstrictors was higher in Group C than Group W (p = 0.0052). Blood pressure during anesthesia was generally lower in Group C than Group W (p < 0.05) despite significantly more doses of ephedrine and phenylephrine administrated in Group C (p = 0.0246 and p = 0.0327, respectively). The incidence of postoperative hypertension did not differ between Groups (p = 0.3793). Estimated glomerular filtration rate (eGFR) on the preoperative day did not differ between Groups (p = 0.7045), while eGFR was slightly lower in Group C than Group W on the first and third postoperative days (p = 0.0400 and p = 0.0088, respectively), although clinically relevant acute kidney injury did not develop. Conclusions: Continuing ARB/CCB combination tablets preoperatively in patients undergoing minor surgery increased the incidence of hypotension during anesthesia, increased requirements of vasoconstrictors to treat hypotension, and might deteriorate postoperative renal function, albeit slightly. These results suggest that withholding ARB/CCB tablets preoperatively is preferable to continuing them. Clinical trial registration: This trial is registered with the Japan Registry of Clinical Trials (jRCT) at Japanese Ministry of Health, Labour, and Welfare (Trial ID: jRCT1031190027).